Benzinga · Aug 7, 2026
Citigroup Maintains Buy on Scholar Rock Holding, Raises Price Target to $60
Citigroup analyst Geoff Meacham maintains Scholar Rock Holding (NASDAQ:SRRK) with a Buy and raises the price target from $58 to $60.
SR
NASDAQ · SRRK
Scholar Rock Holding Corporation
Healthcare · Biotechnology
$52.52
Down-$0.54 (-1.02%)
Updated Aug 16, 2026, 10:21 AM
SID Score
6.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.78B
- P/E ratio
- -15.08
- Dividend yield
- 0.00%
- 52-week range
- $27.07 – $58.49
- Volume
- 496.6K
- Avg. volume
- 2.6M
Price performance
SRRK price history
1M range · 20 trading sessions · Daily adjusted prices
SRRK closed at $52.52 after 20 trading sessions, up 3.67% for the selected period.
- Last close
- $52.52
- Period change
- +3.67%
- Period low
- $45.85
- Period high
- $53.82
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $52.94 | $52.965 | $51.50 | $52.52 | 496.6K |
| Aug 13, 2026 | $54.84 | $55.00 | $52.68 | $53.06 | 942.96K |
| Aug 12, 2026 | $52.18 | $54.70 | $51.85 | $53.82 | 899.25K |
| Aug 11, 2026 | $52.12 | $53.125 | $51.2491 | $52.07 | 853.9K |
| Aug 10, 2026 | $52.51 | $52.68 | $50.69 | $51.89 | 827.08K |
| Aug 7, 2026 | $53.30 | $53.6799 | $50.765 | $52.92 | 958.44K |
| Aug 6, 2026 | $50.21 | $53.62 | $47.99 | $52.64 | 1.62M |
| Aug 5, 2026 | $48.07 | $49.06 | $47.12 | $47.87 | 1.05M |
| Aug 4, 2026 | $46.38 | $48.18 | $46.325 | $47.79 | 767.36K |
| Aug 3, 2026 | $47.45 | $47.505 | $45.73 | $45.85 | 905.23K |
| Jul 31, 2026 | $49.04 | $49.33 | $46.92 | $47.295 | 786.74K |
| Jul 30, 2026 | $49.18 | $50.11 | $48.2901 | $48.99 | 2.1M |
| Jul 29, 2026 | $49.30 | $50.00 | $48.62 | $49.06 | 1.09M |
| Jul 28, 2026 | $48.98 | $49.515 | $47.29 | $49.37 | 943.85K |
| Jul 27, 2026 | $48.63 | $50.12 | $48.21 | $48.93 | 1.25M |
| Jul 24, 2026 | $49.71 | $49.95 | $47.54 | $47.67 | 838.71K |
| Jul 23, 2026 | $47.43 | $49.66 | $47.295 | $49.48 | 1.03M |
| Jul 22, 2026 | $50.43 | $50.53 | $47.275 | $48.30 | 1.61M |
| Jul 21, 2026 | $50.48 | $51.46 | $50.355 | $50.88 | 824.45K |
| Jul 20, 2026 | $52.72 | $53.33 | $50.36 | $50.66 | 898.23K |
Latest SRRK news
The latest Smart Investors Daily articles mentioning SRRK.
Stock researchCompany · Overview
SRRK research
Overview
Company profile and research snapshot.
Company profile
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $49.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 13, 2026 | JP Morgan | Overweight | — |
| Aug 10, 2026 | Wedbush | Outperform | — |
| Aug 10, 2026 | HC Wainwright & Co. | Buy | — |
| Aug 7, 2026 | Citigroup | Buy | — |
| Jul 21, 2026 | Wedbush | Outperform | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 7, 2026
Scholar Rock Removes Catalent Indiana From Apitegromab BLA After FDA OAI Classification; FDA Review Remains On Track for Sept. 30 PDUFA Using Second Fill-Finish Site
Today, August 7, 2026, Scholar Rock received customer notification from Catalent Indiana LLC (part of Novo Nordisk) that FDA classified the April 2026 site inspection of Catalent Indiana fill-finish facility as Official
ChartMill · Aug 6, 2026
Scholar Rock (NASDAQ:SRRK) Rallies 17% as Regulatory Catalysts Outweigh In-Line Q2 Results
Scholar Rock beats Q2 EPS estimates, stock jumps 17% as FDA review for apitegromab progresses; PDUFA date set for Sept 2026.
SeekingAlpha · Aug 6, 2026
Scholar Rock Holding Corporation (SRRK) Q2 2026 Earnings Call Transcript
Scholar Rock Holding Corporation (SRRK) Q2 2026 Earnings Call August 6, 2026 8:00 AM EDTCompany ParticipantsLaura Ekas - Vice President of Investor...
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
